SCHEMBL14976359

SCHEMBL14976359

CC1(O)OO1.[MgH2]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL219644 0.95
SCHEMBL19915169 0.90
SCHEMBL28850213 0.90
SCHEMBL28858935 0.90
SCHEMBL28278458 0.90
SCHEMBL25337267 0.90
SCHEMBL9468143 0.90
SCHEMBL7979315 0.90
SCHEMBL9581092 0.90
SCHEMBL28231170 0.90

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114605131-A Magnesium oxide acetate adhesive for cold consolidation forming of solid powder 南阳师范学院 2022-06-10 CN disclosed
CN-105924961-B A kind of high heat conduction plasticity composite filling material 广州大学 2018-08-28 CN disclosed
CN-105924961-A Composite filling material with high thermal conductivity and plasticity 广州大学 2016-09-07 CN disclosed
EP-2782586-A1 IMPROVED SYNERGISTIC ANTI-DIABETIC COMPOSITIONS Ozstar Therapeutics Pty Ltd (AU) 2014-10-01 EP disclosed
WO-2013075172-A1 IMPROVED SYNERGISTIC ANTI-DIABETIC COMPOSITIONS OZSTAR THERAPEUTICS PTY LTD (AU) 2013-05-30 WO disclosed